Adiponectin and AdipoR1 regulate PGC-1α and mitochondria by Ca2+ and AMPK/SIRT1 (original) (raw)
Scherer, P. E., Williams, S., Fogliano, M., Baldini, G. & Lodish, H. F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem.270, 26746–26749 (1995) CASPubMed Google Scholar
Hu, E., Liang, P. & Spiegelman, B. M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem.271, 10697–10703 (1996) CASPubMed Google Scholar
Maeda, K. et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem. Biophys. Res. Commun.221, 286–289 (1996) CASPubMed Google Scholar
Nakano, Y., Tobe, T., Choi-Miura, N.-H., Mazda, T. & Tomita, M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J. Biochem.120, 803–812 (1996) CASPubMed Google Scholar
Hotta, K. et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol.20, 1595–1599 (2000) CASPubMed Google Scholar
Fruebis, J. et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl Acad. Sci. USA98, 2005–2010 (2001) ADSCASPubMed Google Scholar
Yamauchi, T. et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Med.7, 941–946 (2001) CASPubMed Google Scholar
Berg, A. H., Combs, T. P., Du, X., Brownlee, M. & Scherer, P. E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nature Med.7, 947–953 (2001) CASPubMed Google Scholar
Kubota, N. et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem.277, 25863–25866 (2002) CASPubMed Google Scholar
Maeda, N. et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nature Med.8, 731–737 (2002) ADSCASPubMed Google Scholar
Yamauchi, T. et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Med.8, 1288–1295 (2002) CASPubMed Google Scholar
Tomas, E. et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl Acad. Sci. USA99, 16309–16313 (2002) ADSCASPubMed Google Scholar
Kahn, B. B., Alquier, T., Carling, D. & Hardie, D. G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab.1, 15–25 (2005) CASPubMed Google Scholar
Kersten, S., Desvergne, B. & Wahli, W. Roles of PPARs in health and disease. Nature405, 421–424 (2000) ADSCASPubMed Google Scholar
Yamauchi, T. et al. Globular adiponectin protected ob/ob mice from diabetes and apoE deficient mice from atherosclerosis. J. Biol. Chem.278, 2461–2468 (2003) CASPubMed Google Scholar
Yamauchi, T. et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature423, 762–769 (2003) ADSCASPubMed Google Scholar
Wess, J. G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition. FASEB J.11, 346–354 (1997) CASPubMed Google Scholar
Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y. & Shimizu, T. A. G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature387, 620–624 (1997) ADSCASPubMed Google Scholar
Scheer, A., Fanelli, F., Costa, T., De Benedetti, P. G. & Cotecchia, S. Constitutively active mutants of the α1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation. EMBO J.15, 3566–3578 (1996) CASPubMedPubMed Central Google Scholar
Yamauchi, T. et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nature Med.13, 332–339 (2007) CASPubMed Google Scholar
Petersen, K. F. et al. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med.350, 664–671 (2004) CASPubMedPubMed Central Google Scholar
Wu, Z. et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell98, 115–124 (1999) CASPubMed Google Scholar
Mootha, V. K. et al. Errα and Gabpa/b specify PGC-1α-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc. Natl Acad. Sci. USA101, 6570–6575 (2004) ADSCASPubMed Google Scholar
Berchtold, M. W. et al. Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease. Physiol. Rev.80, 1215–1265 (2000) CASPubMed Google Scholar
Wu, H. et al. MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J.19, 1963–1973 (2000) CASPubMedPubMed Central Google Scholar
Hotamisligil, G. S. Inflammation and metabolic disorders. Nature444, 860–867 (2006) ADSCASPubMed Google Scholar
Um, S. H. et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature431, 200–205 (2004) ADSCASPubMed Google Scholar
Hawley, S. A. et al. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem.271, 27879–27887 (1996) CASPubMed Google Scholar
Hawley, S. A. et al. Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab.2, 9–19 (2005) CASPubMed Google Scholar
Woods, A. et al. Ca2+/calmodulin-dependent protein kinase kinase-β acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab.2, 21–33 (2005) CASPubMed Google Scholar
Jäger, S., Handschin, C., St-Pierre, J. & Spiegelman, B. M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α. Proc. Natl Acad. Sci. USA104, 12017–12022 (2007) ADSPubMed Google Scholar
Rodgers, J. T. et al. Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1. Nature434, 113–118 (2005) ADSCASPubMed Google Scholar
Guarente, L. Sirtuins as potential targets for metabolic syndrome. Nature444, 868–874 (2006) ADSCASPubMed Google Scholar
Tokumitsu, H. et al. STO-609, a specific inhibitor of the Ca2+/calmodulin-dependent protein kinase kinase. J. Biol. Chem.277, 15813–15818 (2002) CASPubMed Google Scholar
Tóth, A. et al. Quantitative assessment of [Ca2+]i levels in rat skeletal muscle in vivo . Am. J. Physiol. Heart Circ. Physiol.275, H1652–H1662 (1998) Google Scholar
Shkryl, V. M. & Shirokova, N. Transfer and tunneling of Ca2+ from sarcoplasmic reticulum to mitochondria in skeletal muscle. J. Biol. Chem.281, 1547–1554 (2006) CASPubMed Google Scholar
Anderson, K. A. et al. Components of a calmodulin-dependent protein kinase cascade. Molecular cloning, functional characterization and cellular localization of Ca2+/calmodulin-dependent protein kinase kinase beta. J. Biol. Chem.273, 31880–31889 (1998) CASPubMed Google Scholar
Soderling, T. R. The Ca-calmodulin-dependent protein kinase cascade. Trends Biochem. Sci.24, 232–236 (1999) CASPubMed Google Scholar
Handschin, C. & Spiegelman, B. M. The role of exercise and PGC1α in inflammation and chronic disease. Nature454, 463–469 (2008) ADSCASPubMedPubMed Central Google Scholar
Handschin, C. et al. Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1α muscle-specific knock-out animals. J. Biol. Chem.282, 30014–30021 (2007) CASPubMed Google Scholar
Mootha, V. K. et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature Genet.34, 267–273 (2003) ADSCASPubMed Google Scholar
Patti, M. E. et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc. Natl Acad. Sci. USA100, 8466–8471 (2003) ADSCASPubMed Google Scholar
Wang, C. et al. Adiponectin sensitizes insulin signaling by reducing p70 S6 kinase-mediated serine phosphorylation of IRS-1. J. Biol. Chem.282, 7991–7996 (2007) CASPubMed Google Scholar
Houstis, N., Rosen, E. D. & Lander, E. S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature440, 944–948 (2006) ADSCASPubMed Google Scholar
St-Pierre, J. et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1transcriptional coactivators. Cell127, 397–408 (2006) CASPubMed Google Scholar